Company intelligence / Profile preview

Balch Hill Partners

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Balch Hill Partners is an activist investment management firm specifically focused on the biotechnology, pharmaceutical, and healthcare sectors. The firm typically takes concentrated equity positions in small- and mid-cap life science companies and is known for engaging in shareholder activism to influence corporate governance, strategic direction, or management changes. Led by Portfolio Manager Simon J. Michael and based in San Francisco, the firm has historically been involved in high-profile campaigns and board nominations at companies such as PLX Technology and Verrica Pharmaceuticals. Balch Hill Partners serves as an institutional investor that identifies undervalued opportunities within the healthcare market to drive shareholder value through active engagement.

Industry: Investors

Beyond the preview

Go deeper on Balch Hill Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Balch Hill Partners.

Explore the full profile